Myocardial interstitial fibrosis contributes to left ventricular dysfunction leading to the
development of heart failure. Basic research has provided abundant evidence for the …

Despite major improvements in transcatheter aortic valve replacement (TAVR)
periprocedural complications in recent years, the occurrence of conduction disturbances has …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Background: Tricuspid regurgitation is associated with increased rates of heart failure (HF)
and mortality. Transcatheter tricuspid valve interventions (TTVI) are promising, but the …

Objectives: A large, prospective international registry was developed to evaluate the initial
clinical applications of transcatheter tricuspid valve intervention (TTVI) with different devices …

The regulatory landscape for device-based heart failure (HF) therapies has seen a major
shift in the last 7 years. In 2013, the US Food and Drug Administration released guidance for …

In minimally invasive endovascular procedures, surgeons rely on catheters with low
dexterity and high aspect ratios to reach an anatomical target. However, the environment …

Tricuspid regurgitation (TR) is a highly prevalent valvular heart disease and is associated
with an increased risk of cardiovascular events and death at long‐term follow‐up. Functional …

Background Quantitation of tricuspid regurgitant (TR) severity can be challenging with
conventional echocardiographic imaging and may be better evaluated using cardiovascular …

Objectives A novel tricuspid regurgitation (TR) grading system, using vena contracta (VC)
width and effective regurgitant orifice area (EROA), was proposed and validated based on …